SDGR - Rasio utang marang kapitalisasi buku Schrödinger Inc.

Tandha merek Schrödinger Inc. (SDGR)

Schrodinger, Inc. (SDGR) possesses significant market influence, as its quantum physics-based software radically reduces drug development timelines. The stock's price history confirms the significance of these technologies, with the current metric standing at 0.31. The company has created an indispensable digital environment for biochemistry by integrating cloud computing with simulation. High computational load is driving a systematic expansion of infrastructure to ensure seamless operations for clients.

Schrodinger Corp (SDGR) - Utang-utang marang nilai buku saka 04.07.2022 nganti 28.10.2026
Produk merek Schrodinger Inc

To identify fundamental support for Schrodinger, Inc. (SDGR), it is essential to evaluate the balance between debt obligations and equity, which is critical when financing the R&D pipeline and the development of the AI platform. By analyzing the debt-to-market cap chart, an investor determines the degree of financial leverage and the risk of over-indebtedness, where a declining ratio confirms the asset's high autonomy and reliability during the development of new drugs.

Karo sapa Schrodinger, Inc. saingan

Utang marang nilai buku Veeva Systems Inc.|doximity.com - Rasio utang marang aset resik|HQY: Rasio utang marang kapitalisasi buku|WAY - Utang marang nilai buku|Utang-utang marang kapitalisasi buku CRVL|Privia Medical Group (PRVA) - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Huron Consulting Group (HURN)|Rasio utang marang nilai buku CERT|OMCL (Omnicell) - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik GoodRx Inc (GDRX)|Phreesia Corp - Utang-utang marang kapitalisasi buku|Utang marang nilai buku Omada OMDA|Utang-utang marang kapitalisasi buku Evolent Health, Inc. (EVH)|HSTM: Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku Definitive Healthcare Corp. DH|CCSI (Consensus Cloud Solutions Inc) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku AGL (agilon health Inc)|Utang-utang marang nilai buku Absci Bio|Utang-utang marang kapitalisasi buku So-Young International SY|Rasio utang marang nilai buku National Research Corporation (NRC)|Utang-utang marang kapitalisasi buku SPOK|OptimizeRx Corp - Utang-utang marang aset resik|CPSI (TBRG) - Rasio utang marang kapitalisasi buku|SLP - Rasio utang marang nilai buku|Utang-utang marang kapitalisasi buku SOPH (sophiagenetics.com)|healthcatalyst.com (HCAT) - Utang marang aset resik|Utang-utang marang kapitalisasi buku CCLD (CareCloud Inc.)|Utang-utang marang nilai buku RSSS|DLH Holdings Corp. (DLHC) - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik onemednet.com ONMD|Utang marang nilai buku Scienture Holdings Inc|Rasio utang marang aset resik healthcaretriangle.com HCTI|Utang-utang marang kapitalisasi buku ISPC (iSpecimen Corp)|BFRG: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku SCWorx Corporation|MSP Recovery Corp (MSPR) - Rasio utang marang nilai buku|Utang-utang marang kapitalisasi buku ICCT|Utang marang nilai buku trxadehealth.com (MEDS)|ORGS (Orgenesis) - Utang marang nilai buku|Utang-utang marang aset resik RCM (r1rcm.com)|Rasio utang marang kapitalisasi buku SHCR|Utang-utang marang aset resik Streamline Health, Inc. STRM|Syra Health Corp. (SYRA) - Utang-utang marang kapitalisasi buku|AMEH - Rasio utang marang nilai buku|Utang-utang marang kapitalisasi buku MODN (Model N)|NXGN (NextGen Healthcare Inc) - Utang marang aset resik